335 related articles for article (PubMed ID: 27497962)
1. Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism.
Wang M; Li Y; Zhou K; Zhang G; Wang Y; Liu T; Zhang Y; Guo A; An Y
Cell Physiol Biochem; 2016; 39(3):860-70. PubMed ID: 27497962
[TBL] [Abstract][Full Text] [Related]
2. Fenofibrate inhibits aldosterone-induced apoptosis in adult rat ventricular myocytes via stress-activated kinase-dependent mechanisms.
De Silva DS; Wilson RM; Hutchinson C; Ip PC; Garcia AG; Lancel S; Ito M; Pimentel DR; Sam F
Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1983-93. PubMed ID: 19395558
[TBL] [Abstract][Full Text] [Related]
3. Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice.
Hirata A; Maeda N; Hiuge A; Hibuse T; Fujita K; Okada T; Kihara S; Funahashi T; Shimomura I
Cardiovasc Res; 2009 Oct; 84(1):164-72. PubMed ID: 19505930
[TBL] [Abstract][Full Text] [Related]
4. Caveolin 1 Modulates Aldosterone-Mediated Pathways of Glucose and Lipid Homeostasis.
Baudrand R; Gupta N; Garza AE; Vaidya A; Leopold JA; Hopkins PN; Jeunemaitre X; Ferri C; Romero JR; Williams J; Loscalzo J; Adler GK; Williams GH; Pojoga LH
J Am Heart Assoc; 2016 Sep; 5(10):. PubMed ID: 27680666
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo.
Messaoudi S; Gravez B; Tarjus A; Pelloux V; Ouvrard-Pascaud A; Delcayre C; Samuel J; Launay JM; Sierra-Ramos C; Alvarez de la Rosa D; Clément K; Farman N; Jaisser F
Hypertension; 2013 Feb; 61(2):361-7. PubMed ID: 23297371
[TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines.
Guo C; Ricchiuti V; Lian BQ; Yao TM; Coutinho P; Romero JR; Li J; Williams GH; Adler GK
Circulation; 2008 Apr; 117(17):2253-61. PubMed ID: 18427128
[TBL] [Abstract][Full Text] [Related]
7. Non-genomic effects of spironolactone and eplerenone in cardiomyocytes of neonatal Wistar rats: do they evoke cardioprotective pathways?
Hermidorff MM; Faria Gde O; Amâncio Gde C; de Assis LV; Isoldi MC
Biochem Cell Biol; 2015 Feb; 93(1):83-93. PubMed ID: 25488178
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone upregulates connective tissue growth factor gene expression via p38 MAPK pathway and mineralocorticoid receptor in ventricular myocytes.
Lee YS; Kim JA; Kim KL; Jang HS; Kim JM; Lee JY; Shin IS; Lee JS; Suh W; Choi JH; Jeon ES; Byun J; Kim DK
J Korean Med Sci; 2004 Dec; 19(6):805-11. PubMed ID: 15608389
[TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans.
Hosoya K; Minakuchi H; Wakino S; Fujimura K; Hasegawa K; Komatsu M; Yoshifuji A; Futatsugi K; Shinozuka K; Washida N; Kanda T; Tokuyama H; Hayashi K; Itoh H
Kidney Int; 2015 Apr; 87(4):749-60. PubMed ID: 25337775
[TBL] [Abstract][Full Text] [Related]
11. Cross-talk between mineralocorticoid receptor/angiotensin II type 1 receptor and mitogen-activated protein kinase pathways underlies aldosterone-induced atrial fibrotic responses in HL-1 cardiomyocytes.
Tsai CF; Yang SF; Chu HJ; Ueng KC
Int J Cardiol; 2013 Oct; 169(1):17-28. PubMed ID: 24120080
[TBL] [Abstract][Full Text] [Related]
12. The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes.
Gravez B; Tarjus A; Jimenez-Canino R; El Moghrabi S; Messaoudi S; Alvarez de la Rosa D; Jaisser F
PLoS One; 2013; 8(9):e73737. PubMed ID: 24040049
[TBL] [Abstract][Full Text] [Related]
13. Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism.
Urbanet R; Pilon C; Calcagno A; Peschechera A; Hubert EL; Giacchetti G; Gomez-Sanchez C; Mulatero P; Toffanin M; Sonino N; Zennaro MC; Giorgino F; Vettor R; Fallo F
J Clin Endocrinol Metab; 2010 Aug; 95(8):4037-42. PubMed ID: 20484481
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone, but not angiotensin II, reduces angiotensin converting enzyme 2 gene expression levels in cultured neonatal rat cardiomyocytes.
Yamamuro M; Yoshimura M; Nakayama M; Abe K; Sumida H; Sugiyama S; Saito Y; Nakao K; Yasue H; Ogawa H
Circ J; 2008 Aug; 72(8):1346-50. PubMed ID: 18654024
[TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid and angiotensin receptor antagonism during hyperaldosteronemia.
Mihailidou AS; Mardini M; Funder JW; Raison M
Hypertension; 2002 Aug; 40(2):124-9. PubMed ID: 12154101
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
[TBL] [Abstract][Full Text] [Related]
17. Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors.
Nguyen Dinh Cat A; Briones AM; Callera GE; Yogi A; He Y; Montezano AC; Touyz RM
Hypertension; 2011 Sep; 58(3):479-88. PubMed ID: 21788604
[TBL] [Abstract][Full Text] [Related]
18. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
19. Spironolactone suppresses aldosterone-induced Kv1.5 expression by attenuating mineralocorticoid receptor-Nox1/2/4-mediated ROS generation in neonatal rat atrial myocytes.
Lu G; Li J; Zhai Y; Li Q; Xie D; Zhang J; Xiao Y; Gao X
Biochem Biophys Res Commun; 2019 Dec; 520(2):379-384. PubMed ID: 31606204
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of mineralocorticoid receptor blockade against neuropathy in experimental diabetic rats.
Takata H; Takeda Y; Zhu A; Cheng Y; Yoneda T; Demura M; Yagi K; Karashima S; Yamagishi M
Diabetes Obes Metab; 2012 Feb; 14(2):155-62. PubMed ID: 21951301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
